Anne Rigg
Impact in
- Oncology top 10%
- COVID-19 and healthcare impacts
- CAR-T cell therapy research
Papers in
- Oncology 16
- COVID-19 and healthcare impacts 8
-
- Healthcare cost, quality, practices 3
- Co-authors
- Nicholas R. Lemoine (3 shared papers)Mieke Van Hemelrijck (9 shared papers)Charlotte Moss (7 shared papers)Beth Russell (7 shared papers)Karol Sikora (2 shared papers)Hardev Pandha (1 shared paper)Justin C. St. John (1 shared paper)Graham Thornicroft (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Future Oncology (3 papers)Breast Cancer Research and Treatment (3 papers)British Journal of Cancer (3 papers)European Journal of Cancer (2 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Anne Rigg
33 papers receiving 955 citations
Peers
Comparison fields: 5 of 102
- Oncology 302
- Cancer Research 100
- Infectious Diseases 122
- Neurology 80
- Biotechnology 42
Countries citing papers authored by Anne Rigg
This map shows the geographic impact of Anne Rigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Rigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Rigg more than expected).
Fields of papers citing papers by Anne Rigg
This network shows the impact of papers produced by Anne Rigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Rigg. The network helps show where Anne Rigg may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne Rigg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 213 | |
| 2 | 2010 | 128 | |
| 3 | 1999 | 103 | |
| 4 | 2006 | 98 | |
| 5 | 2007 | 82 | |
| 6 | 2000 | 67 | |
| 7 | 2001 | 63 | |
| 8 | 2001 | 28 | |
| 9 | 2020 | 27 | |
| 10 | 2021 | 27 | |
| 11 | 1997 | 25 | |
| 12 | 1997 | 21 | |
| 13 | 2019 | 17 | |
| 14 | 1997 | 12 | |
| 15 | 2021 | 11 | |
| 16 | 2020 | 8 | |
| 17 | 2022 | 7 | |
| 18 | 2023 | 6 | |
| 19 | 2017 | 6 | |
| 20 | 2020 | 5 |
About Anne Rigg
Anne Rigg is a scholar working on Oncology, General Health Professions, Cancer Research, Infectious Diseases and Molecular Biology, having authored 36 papers that have together received 985 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (8 papers), Breast Cancer Treatment Studies (4 papers), COVID-19 Clinical Research Studies (4 papers), Healthcare cost, quality, practices (3 papers), Economic and Financial Impacts of Cancer (3 papers), Ovarian cancer diagnosis and treatment (2 papers), Virus-based gene therapy research (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Oncology (302 citations), Cancer Research (100 citations), Infectious Diseases (122 citations), Neurology (80 citations) and Biotechnology (42 citations). Anne Rigg has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Nicholas R. Lemoine, Mieke Van Hemelrijck, Charlotte Moss, Beth Russell, Karol Sikora, Hardev Pandha, Justin C. St. John, Graham Thornicroft, Heidi Lempp and Elizabeth Davies. Their work appears in journals such as Journal of Clinical Oncology, Future Oncology, Breast Cancer Research and Treatment, British Journal of Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.